KMR Site Performance Data Tops 125,000 Sites - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
KMR Site Performance Data Tops 125,000 Sites

Source: Applied Clinical Trials

KMR Group has completed its latest upload of current site performance data into the Site Scorecard Tool. Site Scorecard contains site performance data, providing companies with aggregated details on a given site’s clinical trial performance directly from 12 major biopharma companies. The tool now contains over 125,000 unique records of global site performance information, at 40,000 distinct sites in all regions and all indications.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
7%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here